Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

<< Previous

Bullboard Posts

Next >>

Post by 24minus7on Nov 20, 2024 6:44pm

109 Views

Post# 36322768

Promising Teamwork Approach

A new approach: Instead of just covering up wrinkles, TFC-1326 tries to tackle what causes skin to age in the first place. It does this by encouraging the skin to repair itself and make more collagen (which keeps skin firm).
Cell teamwork: The study highlights how important it is for different types of skin cells to work together, especially cells called fibroblasts and adipocytes. TFC-1326 seems to boost this teamwork, leading to healthier, younger-looking skin.
Promising results: In just 8 weeks, people using TFC-1326 saw improvements in their skin's glow, firmness, and wrinkles. This is exciting because it happened pretty quickly!

(*^^)/*

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project